comparemela.com

Latest Breaking News On - Long acting injectables - Page 3 : comparemela.com

The promise of long-acting injectables

Long-acting injectables have huge untapped clinical potential for patients and caregivers, say experts.

CUNY SPH and NYC Health Department receive grant to study long-acting injectables for HIV

CUNY SPH and NYC Health Department receive grant to study long-acting injectables for HIV
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.

High Viscosity Formulations Developing An Effective Primary Drug Container System

High Viscosity Formulations: Developing An Effective Primary Drug Container System By Susanna White, Oval Medical Technologies The past few years have seen a significant increase in the number of high viscosity (HV) formulations (100 – 1000 cP) being developed. Innovations in the field of biologics, as well as an increased interest in the use of Long Acting Injectables (LAIs), mean that autoinjector developers are constantly being challenged by new formulations with increasingly complex flow behaviours. These new formulations can provide a great number of benefits for patients and health care providers through access to cutting edge therapies and by reducing both dosing frequency and delivered volume. However unless they can be delivered in a patient-orientated manner, these benefits cannot be fully realised. There are a number of steps that autoinjector developers can take to meet the challenges posed by such formulations. This poster will focus on some of the techniques that Ov

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.